Cargando…

Development of prognostic predictive model with neutrophil–lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma

The risk factors have not been well-defined for prognosis in gastric signet ring cell carcinoma (GSRC) patients. This study is designed to prognosticate survival in GSRC patients by establishing and verifying a predictive model with neutrophil–lymphocyte ratio (NLR). A total of 147 GSRC patients fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shihai, Li, Shangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735796/
https://www.ncbi.nlm.nih.gov/pubmed/35029873
http://dx.doi.org/10.1097/MD.0000000000028043
_version_ 1784628320219955200
author Yang, Shihai
Li, Shangdong
author_facet Yang, Shihai
Li, Shangdong
author_sort Yang, Shihai
collection PubMed
description The risk factors have not been well-defined for prognosis in gastric signet ring cell carcinoma (GSRC) patients. This study is designed to prognosticate survival in GSRC patients by establishing and verifying a predictive model with neutrophil–lymphocyte ratio (NLR). A total of 147 GSRC patients from Department of Surgical Oncology, Neimenggu Baogang Hospital, Inner Mongolia Medical University were retrospectively reviewed. A predictive model was established using Cox proportional hazards. The performance of the model was evaluated by ROC curves. In present study, we found that overall survival (OS) (P < .001, Fig. 1A) and tumor recurrence rate (P = .036, Fig. 1B) in the NLR ≤ 2.8 group were significantly better than those in the NLR > 2.8 group. These results showed that NLR ≤ 2.8 was significant prognostic factor related with both OS and tumor recurrence in patients with GSRC. After adjusting for competing risk factors, NLR ≤ 2.8 (hazard ratio [HR]: 2.625, 95% confidence interval [CI]: 1.505–5.3166, P = .003), tumor size (HR: 3.024, 95% CI: 1.521–4.186, P = .005), and tumor metastasis (HR: 3.303, 95% CI: 1.25–4.525, P = .012) remained independent predictors of tumor recurrence rate and OS. Our results showed that comparing with the model without NLR (area under ROC curve: 0.798), the model with NLR (area under ROC curve: 0.826) had significant better predictive power than the model without NLR, which further confirmed the value of NLR in predicting prognosis of patients with GSRC. In conclusion, a high NLR value independently predicts poor survival in patients with GSRC after surgery. The NLR may help oncologists evaluate outcomes of patients received surgical resection and chemotherapy in order to choose alternative therapies for patients with high NLR value.
format Online
Article
Text
id pubmed-8735796
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-87357962022-01-11 Development of prognostic predictive model with neutrophil–lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma Yang, Shihai Li, Shangdong Medicine (Baltimore) 6300 The risk factors have not been well-defined for prognosis in gastric signet ring cell carcinoma (GSRC) patients. This study is designed to prognosticate survival in GSRC patients by establishing and verifying a predictive model with neutrophil–lymphocyte ratio (NLR). A total of 147 GSRC patients from Department of Surgical Oncology, Neimenggu Baogang Hospital, Inner Mongolia Medical University were retrospectively reviewed. A predictive model was established using Cox proportional hazards. The performance of the model was evaluated by ROC curves. In present study, we found that overall survival (OS) (P < .001, Fig. 1A) and tumor recurrence rate (P = .036, Fig. 1B) in the NLR ≤ 2.8 group were significantly better than those in the NLR > 2.8 group. These results showed that NLR ≤ 2.8 was significant prognostic factor related with both OS and tumor recurrence in patients with GSRC. After adjusting for competing risk factors, NLR ≤ 2.8 (hazard ratio [HR]: 2.625, 95% confidence interval [CI]: 1.505–5.3166, P = .003), tumor size (HR: 3.024, 95% CI: 1.521–4.186, P = .005), and tumor metastasis (HR: 3.303, 95% CI: 1.25–4.525, P = .012) remained independent predictors of tumor recurrence rate and OS. Our results showed that comparing with the model without NLR (area under ROC curve: 0.798), the model with NLR (area under ROC curve: 0.826) had significant better predictive power than the model without NLR, which further confirmed the value of NLR in predicting prognosis of patients with GSRC. In conclusion, a high NLR value independently predicts poor survival in patients with GSRC after surgery. The NLR may help oncologists evaluate outcomes of patients received surgical resection and chemotherapy in order to choose alternative therapies for patients with high NLR value. Lippincott Williams & Wilkins 2022-01-07 /pmc/articles/PMC8735796/ /pubmed/35029873 http://dx.doi.org/10.1097/MD.0000000000028043 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 6300
Yang, Shihai
Li, Shangdong
Development of prognostic predictive model with neutrophil–lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma
title Development of prognostic predictive model with neutrophil–lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma
title_full Development of prognostic predictive model with neutrophil–lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma
title_fullStr Development of prognostic predictive model with neutrophil–lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma
title_full_unstemmed Development of prognostic predictive model with neutrophil–lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma
title_short Development of prognostic predictive model with neutrophil–lymphocyte ratio (NLR) in patients with gastric signet ring carcinoma
title_sort development of prognostic predictive model with neutrophil–lymphocyte ratio (nlr) in patients with gastric signet ring carcinoma
topic 6300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735796/
https://www.ncbi.nlm.nih.gov/pubmed/35029873
http://dx.doi.org/10.1097/MD.0000000000028043
work_keys_str_mv AT yangshihai developmentofprognosticpredictivemodelwithneutrophillymphocyterationlrinpatientswithgastricsignetringcarcinoma
AT lishangdong developmentofprognosticpredictivemodelwithneutrophillymphocyterationlrinpatientswithgastricsignetringcarcinoma